Altered NCAM1, NRXN1, NLGN4, and CDH2 Levels in Individuals with Autism Spectrum Disorder and Their Unaffected Siblings
Clinical Psychopharmacology and Neuroscience · 30.11.2026 · 24 (4) · 776-786
DOI: 10.9758/cpn.26.1398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 24.06.2026. Verfasst von Ayşegül Tuğba Hıra Selen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Konya City Hospital, Konya, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Necmettin Erbakan University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Konya City Hospital, Konya, Türkiye.
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
- Department of Biochemistry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
- Department of Pediatrics, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
ORCID-Profile: Ayşegül Tuğba Hıra Selen, Necati Uzun, İbrahim Kılınç, Ahmet Osman Kılıç
Förderung
- Necmettin Erbakan University
Zitieren
APA
Hıra Selen, A. T., Uzun, N., Kılınç, İ., & Kılıç, A. O. (2026). Altered NCAM1, NRXN1, NLGN4, and CDH2 Levels in Individuals with Autism Spectrum Disorder and Their Unaffected Siblings. Clinical Psychopharmacology and Neuroscience, 24(4), 776-786. https://doi.org/10.9758/cpn.26.1398
Vancouver
Hıra Selen AT, Uzun N, Kılınç İ, Kılıç AO. Altered NCAM1, NRXN1, NLGN4, and CDH2 Levels in Individuals with Autism Spectrum Disorder and Their Unaffected Siblings. Clinical Psychopharmacology and Neuroscience. 2026;24(4):776-786. doi:10.9758/cpn.26.1398
BibTeX
@article{HraSelen2026,
author = {Hıra Selen, Ayşegül Tuğba and Uzun, Necati and Kılınç, İbrahim and Kılıç, Ahmet Osman},
title = {Altered NCAM1, NRXN1, NLGN4, and CDH2 Levels in Individuals with Autism Spectrum Disorder and Their Unaffected Siblings},
journal = {Clinical Psychopharmacology and Neuroscience},
year = {2026},
volume = {24},
number = {4},
pages = {776--786},
doi = {10.9758/cpn.26.1398}
}
EUVIMED